Responsible for payer marketing and HCP access/coverage pull-through strategy for the PAH portfolio.

- HCP professional promotion, COVID-19 Vaccine- Direct channel strategy lead, RSV

Responsible for HCP professional promotions. Led the cross-functional core launch team and built the marketing launch plan for Fluzone High-Dose Quadrivalent. Developed a new promotional and creative campaign, which featured the company's first real-world evidence messaging platform utilizing CFL guidelines from FDA. Analyzed portfolio performance and led reporting to leadership. Managed agency of record to ensure timely delivery of tactics within budget.

Developed the 2018 and 2019 strategic plans that ultimately drove ~30% growth over two years. Responsible for HCP medical education strategy and tactics. Drove planning and execution of advisory board meetings. Overhauled the influenza speaker bureau by implementing new approaches to recruitment, training, and KOL engagement while maintaining strict compliance. Led a cross-functional core team that built the franchise's first scientific narrative.

4th and final rotation in a commercial leadership development program.Responsible for developing and accelerating vaccine market development opportunities throughout the region. Ensure marketing and commercial excellence across the endemic vaccines range by supporting regional affiliate brand planning, forecasting, and strategic execution.

3rd of four rotations in a commercial leadership development program.Developed HCP messaging through primary market research and field testing. Led the roll-out of the new messaging platform through the POA cycle. Supported strategic planning and led tactical planning. Developed medical education and professional promotion tactics by working closely with creative agencies to define scope, ensure quality and fulfill MLR requirements.

2nd of four rotations in a commercial leadership development program.Planned and facilitated product and selling skills training for new hire orientation and POA meetings. Partnered with the marketing team to strengthen sales force tactical execution and use of product messages.

1st of four rotations in a commercial leadership development program. Responsible for calling on Pediatric and Primary Care physician offices to promote Sanofi Pasteur vaccine portfolio and provide customer service. Exceeded quotas for influenza and meningococcal franchises. Managed customers through supply shortage to ensure effective use of allocations and/or return to use of full product line when inventory was available.

- Designed strategic sourcing cost savings model that was ultimately implemented at the Enterprise level and used to create 2013 JSG procurement business plan and budget.- Identified over $165M in combined development and steady-state savings that resulted from procurement involvement with one drug candidate.- Improved measurement of Advance Sourcing outcomes by developing “Value Metrics” scorecard that identified key activities leading to procurement-generated savings.- Presented business results determined by cost model and scorecard to senior managers including J&J CPO, Sector VP’s, and Enterprise Advance Sourcing Council.

- Managed $150K feasibility analysis of screening method for raw material lot quality assurance.- Conducted bacterial fermentation screening studies budgeted at > $200,000; built experimental model that evaluated in-process performance parameters against validated control data.- Initiated 4 contracts with external analytical service vendors that provided feasibility analysis with crucial technical solutions that were unavailable in-house.- Trained 3 colleagues in laboratory protocols to increase procedural accuracy and throughput.

- Successfully developed a yeast extract nutritional alternative for bacterial manufacturing systems.- Used recombinant DNA technology and cloning methods to build a repertoire of product variants; selected variants on the basis of their correlation with increased manufacturing efficiencies.